SODIUM BICARBONATE ANTACID- sodium bicarbonate powder

Sodium Bicarbonate Antacid by

Drug Labeling and Warnings

Sodium Bicarbonate Antacid by is a Otc medication manufactured, distributed, or labeled by Compania Farmaceutica, S.A. de C.V.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient (in each 1/2 teaspoon)

Sodium bicarbonate 2.52 g

Purpose

Antacid

Uses

• For the relief of heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

Warnings

Do not use​

• more than 3 teaspoons for persons up to 60 years old
• more than 1½ teaspoons for persons 60 years or older in a 24-hour period
• more than the maximum dosage of this product for more than 2 weeks, except under the advice and supervision of a physician.

Ask a doctor or pharmacist before use if you

are presently taking a prescription drug. Antacids may interact with certain prescription drugs.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• Persons Up To 60 Years Old: Take ¼ to ½ teaspoon up to 4 times a day
• Persons 60 Years or Older: take ¼ teaspoon up to 4 times a day or ½ teaspoon up to 3 times a day.

Other information

• Sodium Content per ½ tsp. 685 mg
• Store at 86°F/30°C or cooler

Inactive ingredients

none

Package Labeling:

INGREDIENTS AND APPEARANCE

SODIUM BICARBONATE ANTACID 
sodium bicarbonate powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71230-001
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SODIUM BICARBONATE (UNII: 8MDF5V39QO) (SODIUM CATION - UNII:LYR4M0NH37)	SODIUM BICARBONATE	2.52 g  in 2.52 g

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71230-001-12	12 g in 1 POUCH; Type 0: Not a Combination Product	02/16/2017

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part331	02/16/2017

Labeler - Compania Farmaceutica, S.A. de C.V. (816053340)